Literature DB >> 3729363

Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit.

A Andremont, H Sancho-Garnier, C Tancrede.   

Abstract

Intestinal colonization by highly erythromycin-resistant members of the family Enterobacteriaceae was surveyed for 4 years in a hematology-oncology unit. Fifty-four of 555 patients (9.7%) were colonized, each with a different strain. The incidence of intestinal carriage was not correlated with erythromycin consumption in the ward but was strongly associated with individual exposure to erythromycin.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3729363      PMCID： PMC180510          DOI： 10.1128/AAC.29.6.1104

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration.

Authors:  R L Nichols; R E Condon; A R DiSanto
Journal:  Arch Surg       Date:  1977-12

2.  Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins.

Authors:  H G Wittmann; G Stöffler; D Apirion; L Rosen; K Tanaka; M Tamaki; R Takata; S Dekio; E Otaka
Journal:  Mol Gen Genet       Date:  1973-12-20

3.  Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.

Authors:  A Andremont; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

4.  Influence of erythromycin on the normal human flora and colonization of the oral cavity, throat and colon.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1982

5.  [Effect of erythromycin on the populations of enterobacteria in the human digestive tract].

Authors:  C Tancrede; A Andremont; N Guerlin
Journal:  Nouv Presse Med       Date:  1980-10-11

6.  In vitro comparison of rosamicin and erythromycin against urinary tract pathogens.

Authors:  T C Eickhoff; J M Ehret
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora.

Authors:  A Andremont; P Raibaud; C Tancrède
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

8.  Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man.

Authors:  C L Hartley; H M Clements; K B Linton
Journal:  J Med Microbiol       Date:  1978-05       Impact factor: 2.472

9.  Intestinal beta-lactamase activity in ampicillin-induced, Clostridium difficile-associated ileocecitis.

Authors:  R D Rolfe; S M Finegold
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

10.  Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin.

Authors:  A Andremont; C Tancrede
Journal:  Ann Microbiol (Paris)       Date:  1981 Nov-Dec
View more
  15 in total

1.  Identification of functional amino acids in the macrolide 2'-phosphotransferase II.

Authors:  K Taniguchi; A Nakamura; K Tsurubuchi; A Ishii; K O'Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.

Authors:  S Pecquet; E Chachaty; C Tancrède; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin.

Authors:  J A Retsema; A E Girard; L A Brennan; C R Cimochowski; J A Faiella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

4.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.

Authors:  M H Prevot; A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

5.  Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients.

Authors:  A Andremont; B Marang; C Tancrède; D Baume; C Hill
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 6.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

7.  Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit.

Authors:  C L de Champs; D P Guelon; R M Garnier; M C Poupart; O Y Mansoor; F L Dissait; J L Sirot
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  In vitro activity of azithromycin against bacterial enteric pathogens.

Authors:  M E Gordillo; K V Singh; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli.

Authors:  K O'Hara; K Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Contribution of two different mechanisms to erythromycin resistance in Escherichia coli.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.